|
1
|
Ala92 type 2 deiodinase allele increases risk for the development of hypertension.
|
Hypertension
|
2007
|
1.98
|
|
2
|
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension.
|
Hypertension
|
2006
|
1.72
|
|
3
|
Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.
|
Hypertension
|
2010
|
1.69
|
|
4
|
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
|
Hypertension
|
2013
|
1.55
|
|
5
|
The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.
|
Metabolism
|
2011
|
1.15
|
|
6
|
25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians.
|
J Renin Angiotensin Aldosterone Syst
|
2011
|
1.13
|
|
7
|
A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II.
|
J Hypertens
|
2010
|
1.12
|
|
8
|
The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians.
|
Clin Endocrinol (Oxf)
|
2011
|
1.03
|
|
9
|
The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS.
|
Obesity (Silver Spring)
|
2011
|
0.99
|
|
10
|
Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension.
|
J Clin Endocrinol Metab
|
2011
|
0.98
|
|
11
|
Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension.
|
J Clin Endocrinol Metab
|
2007
|
0.98
|
|
12
|
Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.
|
Cancer
|
2014
|
0.98
|
|
13
|
Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.
|
J Clin Endocrinol Metab
|
2012
|
0.97
|
|
14
|
The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.
|
Eur J Endocrinol
|
2011
|
0.97
|
|
15
|
Relationship between aldosterone and progesterone in the human menstrual cycle.
|
J Clin Endocrinol Metab
|
2006
|
0.96
|
|
16
|
Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.94
|
|
17
|
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses.
|
J Renin Angiotensin Aldosterone Syst
|
2011
|
0.92
|
|
18
|
Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern.
|
Am J Clin Nutr
|
2010
|
0.88
|
|
19
|
The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension.
|
Clin Endocrinol (Oxf)
|
2011
|
0.87
|
|
20
|
The relationship between peroxisome proliferator-activated receptor-gamma and renin: a human genetics study.
|
J Clin Endocrinol Metab
|
2010
|
0.86
|
|
21
|
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus.
|
J Clin Endocrinol Metab
|
2012
|
0.84
|
|
22
|
Familial aggregation of insulin resistance and cardiovascular risk factors in hypertension.
|
J Clin Hypertens (Greenwich)
|
2006
|
0.84
|
|
23
|
The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haplotype approach.
|
Metabolism
|
2011
|
0.83
|
|
24
|
Aldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action.
|
Endocrinology
|
2014
|
0.82
|
|
25
|
Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance.
|
Metabolism
|
2011
|
0.82
|
|
26
|
Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertension.
|
J Clin Endocrinol Metab
|
2012
|
0.81
|
|
27
|
Dietary sodium alters the prevalence of electrocardiogram determined left ventricular hypertrophy in hypertension.
|
Am J Hypertens
|
2009
|
0.80
|
|
28
|
Vitamin D and insulin sensitivity: can gene association and pharmacogenetic studies of the vitamin D receptor provide clarity?
|
Metabolism
|
2012
|
0.79
|
|
29
|
Targeting the hedgehog pathway to treat basal cell carcinoma.
|
J Drugs Dermatol
|
2013
|
0.79
|
|
30
|
Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study.
|
BMC Endocr Disord
|
2013
|
0.79
|
|
31
|
Merkel cells and touch domes: more than mechanosensory functions?
|
Exp Dermatol
|
2014
|
0.78
|
|
32
|
The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes.
|
Metabolism
|
2012
|
0.77
|
|
33
|
Hypertension: spironolactone and resistant hypertension.
|
Nat Rev Endocrinol
|
2010
|
0.76
|
|
34
|
Influence of dietary sodium modulation on electrocardiographic voltage criteria for left ventricular hypertrophy in normotensive individuals.
|
J Investig Med
|
2012
|
0.75
|
|
35
|
Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non-Small Cell Lung Cancer.
|
J Immunother
|
2017
|
0.75
|